Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Share Price Hits Fresh 52-Week High

Glaxosmithkline Pharmaceuticals Ltd. traded at Rs 3,014.95, up 4.57% today, after hitting a fresh 52-week high of Rs 3,030. Its market capitalisation stood at Rs 45,736.24 crore.

Glaxosmithkline Pharmaceuticals Ltd. Share Price moved to Rs 3,014.95 on 19 August 2026, up Rs 131.75 or 4.57% from the previous close of Rs 2,883.20, after touching a fresh 52-week high of Rs 3,030. With a market capitalisation of Rs 45,736.24 crore and turnover of Rs 16.69 crore, the stock has entered the day’s market conversation as a one-year high candidate within the Healthcare space.

For investors tracking Glaxosmithkline Pharmaceuticals Ltd. Share Price Today, the verified data clearly confirms the price event: the stock opened at Rs 2,854.85, traded between Rs 2,854.85 and Rs 3,030, and recorded volume of 55,350 shares by 10:50 AM IST. The move is notable because fresh 52-week highs often draw attention from traders, long-term market participants and screen-based strategies looking at momentum stocks and 52 Week High Stocks.

What the supplied data does not establish is a company-specific catalyst. In other words, the Glaxosmithkline Pharmaceuticals Ltd. Stock News today is the price event itself. That still matters. At Univest, a fresh yearly high can be a useful signal to review price action, valuation, sector positioning and peer standing before the next set of market updates. This Glaxosmithkline Pharmaceuticals Ltd. Share Price Update therefore focuses on what is verified: today’s move, current valuation ratios, sector benchmarks and peer comparison.

Glaxosmithkline Pharmaceuticals Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 3,014.95
Previous Close	Rs 2,883.2
Today's Change	+Rs 131.75 (+4.57%)
Day Open	Rs 2,854.85
Fresh 52-Week High	Rs 3,030
Day Low	Rs 2,854.85
Current Volume	55,350
Turnover	Rs 16.69 crore
Market Capitalisation	Rs 45,736.24 crore

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) traded at Rs 3,014.95. versus the previous close of Rs 2,883.2, a rise of 4.57%. The stock opened at Rs 2,854.85, reached Rs 3,030, touched Rs 2,854.85. Reported volume was 55,350.

Glaxosmithkline Pharmaceuticals Ltd. Share Price Today reflects a sharp intraday move from the open and a successful test of a fresh 52-week peak. The stock opened at Rs 2,854.85, which was also the day’s low, and then climbed to Rs 3,030 before trading at Rs 3,014.95.

The day’s gain of Rs 131.75 over the previous close of Rs 2,883.20 translates into a 4.57% rise, placing the stock among active names in Stock Market Today conversations. The fact that the session low matched the opening price and the intraday high reset the 52-week high suggests buyers controlled the day’s price action for most of the session. The current trading level of Rs 3,014.95 also means the stock held most of its gains even after touching the day’s peak.

Volume stood at 55,350 shares, while turnover reached Rs 16.69 crore. That combination indicates a meaningful value of trades changing hands, which is often why a stock begins to feature in Share Market Today screens, Stocks in News lists and Market Movers discussions. The supplied data confirms a fresh 52-week high and strong daily price action, even though it does not identify a separate company announcement as the trigger.

For readers searching Glaxosmithkline Pharmaceuticals Ltd. Share Price Live or Glaxosmithkline Pharmaceuticals Ltd. News Today, the important point is straightforward: the stock has made a new one-year high within today’s trading range and is sustaining close to that level. The next step is to test whether the current market attention is also supported by the valuation and profitability picture.

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 45,736.24 crore
P/E Ratio	51.17x
P/B Ratio	2.03x
ROE	-0.78%
ROCE	8.31%

Glaxosmithkline Pharmaceuticals Ltd. was valued at a P/E ratio of 51.17x, a P/B ratio of 2.03x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -0.78% and ROCE of 8.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	51.17x
Benchmark Median P/E	20.79x
Benchmark Average P/E	47.16x
Benchmark P/E Range	0x to 1,635.98x
Company P/B Ratio	2.03x
Benchmark Median P/B	1.9x
Company ROE	-0.78%
Benchmark Median ROE	11.09%
Company ROCE	8.31%
Benchmark Median ROCE	13.29%
Company Market Capitalisation	Rs 45,736.24 crore
Benchmark Median Market Cap	Rs 134.22 crore

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) is classified under sector: Healthcare.

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P/E ratio of 51.17x, which is above the benchmark median of 20.79x, a difference of +146.13%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROE of -0.78%, which is below the benchmark median of 11.09%, a difference of -107.03%. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROCE of 8.31%, which is below the benchmark median of 13.29%, a difference of -37.47%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,724.51	51.17	2.03	-0.78	8.31
Beta Drugs Ltd.	BETA	2,697.08	62.93	9.96	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,583.65	33.9	6.99	36.29	42.4
Sai Parenteral's Ltd.	SAIPARENT	2,431.62	167.79	3.07	13.9	12.97
Fredun Pharmaceuticals Ltd.	FREDUN	2,403.56	54.45	8.13	11.42	13.15

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P/E ratio of 51.17x compared with the displayed peer median of 54.45x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.78% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 8.31% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a market capitalisation of Rs 45,736.24 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Glaxosmithkline Pharmaceuticals Ltd.

This stock is attracting attention because the verified data combines a fresh yearly high with a large market capitalisation and sector-relevant valuation metrics. The current setup explains why it is appearing in stock updates and market trends discussions.

• Fresh 52-week high: The stock hit Rs 3,030 and was trading at Rs 3,014.95, up 4.57% on the day.
• Strong intraday move: It opened at Rs 2,854.85, which was also the day’s low, showing a strong upward session.
• Active trading value: Volume reached 55,350 shares and turnover stood at Rs 16.69 crore.
• Large company size: Market capitalisation of Rs 45,736.24 crore stands far above the supplied sector benchmark references.
• Mixed fundamentals: P/E is 51.17 and P/B is 2.03, while ROE is -0.78% and ROCE is 8.31%.
• Sector context: The Healthcare benchmark spans 196 companies, giving investors a broader base for comparison.

About Glaxosmithkline Pharmaceuticals Ltd.

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) is the listed company name in the supplied market dataset, and the stock is being tracked within the Healthcare sector. In this article, the company is being analysed strictly through verified market data tied to its fresh 52-week high event, including price action, market capitalisation, valuation ratios and sector comparison.

The available dataset places GLAXO alongside other Healthcare names such as pharmaceutical and hospital companies in the broader benchmark and peer universe. That sector placement is useful because it allows investors to compare Glaxosmithkline Pharmaceuticals Ltd. Share Price with common market measures such as P/E, P/B, ROE, ROCE and market cap across the same sector. At Univest, this kind of company context helps readers move from headline price action to more structured stock analysis without adding unsupported company claims.

Track Glaxosmithkline Pharmaceuticals Ltd. Share Price on Univest

Use Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors tracking Glaxosmithkline Pharmaceuticals Ltd. Share Price can use Univest to follow live share price moves, 52-week levels, valuation ratios, market capitalisation trends, peer comparison and sector context in one place. For traders and long-term market participants alike, that makes it easier to separate verified stock price data from speculation.

Univest also helps users monitor Glaxosmithkline Pharmaceuticals Ltd. Share Price Today alongside market insights such as turnover, volume behaviour, peer positioning and benchmark valuation data. When a stock reaches a fresh 52-week peak, those data points become especially important in understanding why it is appearing in GLAXO share news, BSE News and broader Indian Stock Market discussions.

Frequently Asked Questions

What is the latest Glaxosmithkline Pharmaceuticals Ltd. share price today?

Ans. Glaxosmithkline Pharmaceuticals Ltd. share price today was Rs 3,014.95 at the time of the event update. The stock was up Rs 131.75, or 4.57%, from the previous close of Rs 2,883.20.

Did Glaxosmithkline Pharmaceuticals Ltd. hit a 52-week high?

Ans. Yes, Glaxosmithkline Pharmaceuticals Ltd. touched a fresh 52-week high of Rs 3,030 during the session. It then traded at Rs 3,014.95, which kept the stock close to its new one-year peak.

Why is Glaxosmithkline Pharmaceuticals Ltd. rising today?

Ans. The supplied data confirms a strong market move, with the stock rising 4.57% and hitting a fresh 52-week high. However, the verified dataset does not establish a separate company-specific catalyst behind today’s move.

What does today’s price action show for GLAXO?

Ans. GLAXO opened at Rs 2,854.85, which was also the day’s low, and climbed to Rs 3,030. That range, along with the close-to-high trading pattern, indicates a strong intraday upward move.

How much trading activity was seen in the stock?

Ans. The stock recorded volume of 55,350 shares and turnover of Rs 16.69 crore by the event time. That level of trading activity helped put the stock into active market and share price update discussions.

What is the market capitalisation of Glaxosmithkline Pharmaceuticals Ltd.?

Ans. Glaxosmithkline Pharmaceuticals Ltd. had a market capitalisation of Rs 45,736.24 crore in the supplied data. That is far above the Healthcare sector benchmark average market cap of Rs 465.93 crore.

How is the stock valued on P/E and P/B?

Ans. The stock is valued at a P/E ratio of 51.17 and a P/B ratio of 2.03. Its P/E is above the sector median of 20.79, while its P/B is near the median of 1.90.

What do the ROE and ROCE numbers indicate?

Ans. The supplied figures show ROE at -0.78% and ROCE at 8.31%. Both are below the Healthcare sector medians of 11.09% for ROE and 13.29% for ROCE in the benchmark snapshot.

How does Glaxosmithkline Pharmaceuticals Ltd. compare with peers?

Ans. The company stands out on scale, with market capitalisation of Rs 45,736.24 crore versus peer figures around Rs 2,403.56 crore to Rs 2,724.51 crore. Its profitability ratios, however, trail several supplied Healthcare peers.

What should investors monitor next in Glaxosmithkline Pharmaceuticals Ltd. stock news?

Ans. Investors may watch whether the stock sustains levels near Rs 3,030, the fresh 52-week high, while tracking valuation at 51.17 times earnings, profitability ratios and its standing against Healthcare sector benchmarks.